Moreover, a search of information in Gene Expression Profiling Interactive Analysis (GEPIA, http://gepia.cancer-pku.cn/index.html) revealed that glioma patients with tumors that displayed high levels of RAB3D expression had shorter survival times (P = 0.0001), suggesting the relevance of RAB3D to the survival of glioma patients (Figure 7G). The gene discussed is RAB3D; the disease is central nervous system cancer.